Bashir Naazish S, Walters Thomas D, Griffiths Anne M, Ungar Wendy J
Program of Child Health Evaluative Sciences, The Hospital for Sick Children Research Institute, Toronto, ON M5G 0A4, Canada.
Division of Gastroenterology, Hepatology and Nutrition, The Hospital for Sick Children, Toronto, ON M5G 1X8, Canada.
Children (Basel). 2021 Apr 27;8(5):343. doi: 10.3390/children8050343.
Health utilities relevant to children are lacking, compromising health funding and policy decisions for children. The Child Health Utility 9D (CHU9D) is a recently developed preference-based health utility instrument designed for use in children. The objective was to examine the validity of the CHU9D in a cohort of 285 Canadian children aged 6.5 to 18 years of age with Crohn's disease (CD) and ulcerative colitis (UC), (collectively inflammatory bowel disease (IBD)). The correlation and agreement between paired CHU9D and Health Utility Index (HUI) assessments were determined with Spearman coefficients and Bland-Altman levels of agreement. Total and domain utilities were calculated for the CHU9D using Australian adult and youth tariffs. Algorithms for HUI2 and HUI3 were used. Domain correlations were determined between domains with expected overlap between instruments. In CD and in UC, correlations between CHU9D, HUI2, and HUI3 utilities ranged between 0.62 to 0.67 and 0.67 to 0.69, respectively ( < 0.05). CHU9D utilities were lower using youth tariffs compared to adult tariffs. A large range in health utilities suggested a heterogeneous quality of life. The CHU9D is a good option for preference-based utility measurement in pediatric IBD. Additional research is required to derive pediatric tariffs to conduct economic evaluation in children.
与儿童相关的健康效用指标缺失,这对儿童健康资金投入和政策决策造成了不利影响。儿童健康效用9维度量表(CHU9D)是最近开发的一种基于偏好的健康效用测量工具,专为儿童设计。目的是在285名年龄在6.5至18岁之间患有克罗恩病(CD)和溃疡性结肠炎(UC)(统称为炎症性肠病(IBD))的加拿大儿童队列中检验CHU9D的有效性。通过Spearman系数和Bland-Altman一致性水平确定配对的CHU9D和健康效用指数(HUI)评估之间的相关性和一致性。使用澳大利亚成人和青少年费率计算CHU9D的总体和领域效用。使用HUI2和HUI3的算法。在工具之间预期有重叠的领域之间确定领域相关性。在CD和UC中,CHU9D、HUI2和HUI3效用之间的相关性分别在0.62至0.67和0.67至0.69之间(<0.05)。与成人费率相比,使用青少年费率时CHU9D效用较低。健康效用的大范围表明生活质量存在异质性。CHU9D是儿科IBD中基于偏好的效用测量的一个不错选择。需要进行更多研究以得出儿科费率,以便在儿童中进行经济评估。